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Abstract
Background: Although cardiovascular disease is the major cause of premature death among Indigenous peoples in
several advanced economies, no acute coronary syndrome (ACS) risk models have been validated in Indigenous
populations. We tested the validity and calibration of three Global Registry of Acute Coronary Events (GRACE) scores
among Aboriginal and non-Aboriginal Australians.
Methods: GRACE scores were calculated at admission or discharge using clinical data, with all-cause deaths
obtained from data linkage. Scores for GRACE models were validated for; 1) in-hospital death, 2) death within
6 months from admission or 3) death within 6 months of discharge (this also for 1 and 5-years mortality).
Results: Aboriginal patient were younger (62 % aged <55 years versus 15 % non-Aboriginal) and their median
GRACE scores lower than non-Aboriginal patients, as was crude mortality at 6 months from admission (6 % vs 10 %)
and at 1 and 5 years. After age stratification, risk scores for Aboriginal patients were equivalent or higher, especially
among those aged <55 years. There was a trend to more deaths after discharge among Aboriginal patients in each
age group, suggesting an age-related under-estimation of risk. The c-statistics for the three GRACE models within
both groups were between 0.75 and 0.79.
Conclusions: We demonstrated for the first time that while the discriminatory capacity of GRACE risk scores among
Indigenous Australians is good, the models may need re-calibrating to improve risk stratification in this and other
Indigenous groups, where age of onset of coronary disease is much younger than among the original reference
population.
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Background
Indigenous populations in several advanced economies
experience higher rates of coronary heart disease (CHD)
and mortality, starting at a younger age than the general
population. The disparity, well-documented among Abo-
riginal and Torres Strait Islander (hereafter Aboriginal)
Australians [1], has been reported among indigenous
people in countries such as the United States (US),
Canada and New Zealand [2–7].
Aboriginal Australians are approximately 3 % of the
total population in Australia and 3.8 % of the state popula-
tion of Western Australian, with around one-third living
in the metropolitan area of the state capital, Perth, and
40 % living in ‘remote’ or ‘very remote’ areas during the
data collection period [8]. Although this Aboriginal popu-
lation is relatively young, with a median age of 21 years
compared with 37 years for the non-Aboriginal popula-
tion, CHD is the leading cause of death. CHD was the
cause of death for 37 % of Aboriginal people aged 45 to
64 years in 2003–2007, compared with 9 % of non-
Aboriginal Australians,[8] and Aboriginal people suffer
coronary events at three times the age-standardised rate
as other Australians, with the greatest difference among
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Aboriginal people aged 35–54 years [9, 10]. Aboriginal pa-
tients also suffer higher case-fatality after acute myocardial
infarction than non-Aboriginals [9, 11, 12].
Among CHD risk models, only the well-validated
Framingham Risk Score, used to estimate the 10-year
risk for a CHD event, has been tested in indigenous
groups [13, 14]. Among remote-dwelling Australian
Aboriginal people, the Framingham model substan-
tially under-estimated risk, especially for women and
young adults [14].
Due to the high incidence of CHD and poorer out-
comes among Aboriginal patients [9–12], accurate esti-
mation of risk at presentation is important to ensure
appropriate intervention to preserve optimal myocardial
function, and to guide ongoing management. The first
Global Registry of Acute Coronary Events (GRACE)
score was developed to enable ‘practical and accurate
prediction of in-hospital mortality’ for individuals pre-
senting with symptoms of acute coronary syndrome
(ACS) [15]. The data for the development of the GRACE
‘in-hospital’ model were gathered from hospitals in 14
countries worldwide. Two additional risk score models
have been developed from the registry; to extend to the
prediction of risk for death within 6 months of admis-
sion, and a score, calculated at discharge, to predict the
risk for death within 6 months from discharge [16, 17].
These three models have been tested and validated in
studies from several countries and retained good dis-
criminatory capacity for predicting death, including
death within one year, and out to five years [18]. A large
scale review found that GRACE models performed bet-
ter than similar ACS risk models. [19] The GRACE risk
calculators are available online and are available for
downloading to portable devices [20].
Despite the higher risk among several indigenous pop-
ulations for CVD [2–7] there are no published results
validating an ACS risk score in an indigenous popula-
tion. As the distribution of age, sex, and risk factors con-
tribute to the performance of risk scores among different
populations, we tested three GRACE models in a cohort
of Western Australian patients admitted for ACS to deter-
mine whether these prognostic models performed equally
well among Aboriginal and non-Aboriginal Australians.
Methods
Study design
This retrospective cohort study used clinical data re-
corded in medical notes during an admission for ACS,
with patients being followed up to five years to deter-
mine vital status. These clinical data were linked to pub-
lic and private hospital administrative data from the
Hospital Morbidity Data Collection (HMDC), one of the
core administrative datasets in the Western Australian
Data Linkage System in which all hospital separations in
the state of Western Australia (WA) are collated for in-
dividuals under a unique identifier [21]. These linked
HMDC records allow person-based analyses, where all
admissions for each patient (including inter-hospital
transfers) can be identified, with data from the WA
Death Registry also linked to these hospital records.
Sample and case selection
The cohort of ACS patients was selected for this study
from two prior studies. The first was a linked data study
to validate diagnoses of acute myocardial infarction (AMI)
recorded in Western Australian administrative data
among patients aged 35–79 years admitted to hospitals in
metropolitan Perth (the capital city) in 2003 [22]. Briefly,
patients with a World Health Organisation International
Classification of Disease (ICD-10 Australian Modification)
code for ACS (I20.0 and I21) recorded in the principal or
subsequent ‘diagnosis’ field, or with a positive cardiac bio-
marker and any other ‘cardiac’ or ‘chest pain’ diagnosis
were identified (I10-I52, R07). Data were collected from
patients’ notes (medical records) for a sample of patients
randomly selected within strata (approximately 50 % of
ACS cases and 5 % of ‘other’ cardiac cases). The stratified
sampling fractions were based on diagnosis ICD codes,
admission type (emergency, booked) and cardiac bio-
marker status [22]. The second study extended the cohort
to include all Aboriginal patients admitted to WA hospi-
tals in 2002–2004 and a random sample of rural non-
Aboriginal patients admitted in 2003 [23]. These ACS
cases, including both metropolitan and rural Aboriginal
and non-Aboriginal admissions over the period 2002–
2004, were used in the current study. The data collection
period coincides with the period of enrolment of patients
to the GRACE Registry [18].
Data linkage and extraction for the studies was under-
taken by the staff at the Data Linkage Unit at the Health
Department of Western Australia.
To address under-identification of Aboriginal status in
administrative health data, patients were classified as
Aboriginal if they were flagged as Aboriginal in any hos-
pital admission in the HMDC data [24]. The index ‘epi-
sode of care’ for this analysis was the first admission
episode (including transfers between rural and tertiary
centres, between other metropolitan hospitals and ter-
tiary centres and between public to private hospitals)
within the study period. De-identified cases were se-
lected for the study if they met the published eligibility
criteria for enrolment in the GRACE study (based on
discharge diagnoses, electrocardiograph [ECG] and bio-
marker data), excluding those discharged from hospital
within one day or who had ACS secondary to another
serious condition or a procedure [16]. The selection of
cases is shown in Fig. 1.
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Data collection
Clinical information was collected from patient medical
records from hospitals throughout WA, including symp-
toms, investigations, laboratory data, medical history and
procedures. The data collection has been described in
detail elsewhere [22, 23]. The electrocardiogram (ECG) re-
cordings were coded using the Minnesota system,[25] and
classified according to the American Heart Association
(AHA) criteria for acute coronary heart disease [26]. Cases
with a principal discharge diagnosis of AMI and with
AHA ECG classification of ‘diagnostic, ST elevation, or
evolving Q waves’ were categorized as ST-elevation myo-
cardial infarction (STEMI). Killip Class categorisation of
acute heart failure (HF) (included in the two risk scores
calculated on admission) was not recorded for 14 patients,
but defaulted to ‘class one’ if they had no history of HF
and no in-hospital HF on the index admission.
Risk score models
The clinical data were used to calculate the three pub-
lished GRACE scores; calculated (1) on admission for
risk of death in-hospital, (2) on admission for risk for
death within 6 months of admission, and (3) at discharge
for risk for death within 6 months of discharge [20].
All models assign a high weighting to age: for example,
under the in-hospital model no points accrue for
patients <40 years, but 58 points accrue to those aged
Fig. 1 Flow chart showing selection of 892 study cases of acute coronary syndrome admitted to hospitals in Western Australia during 2002–2004
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60–69 years, the same as for systolic blood pressure
≤80 mmHg, which is otherwise the highest score for any
level of a factor, and greater than cardiac arrest at admis-
sion (39 points).
The risk scores from the third model (risk for death
within 6-months of hospital discharge) for Aboriginal and
non-Aboriginal patients were divided into tertiles for com-
parison with the tertiles of risk score published from the
GRACE study [20]. These stratify patients into low, inter-
mediate and high risk for death according to their diagno-
sis of STEMI or non-STEMI/unstable angina (UA).
The scores obtained on admission were also catego-
rized by the probability of risk for all-cause death at
6 months estimated from the GRACE study formula,[23]
for calibration against the observed proportion of deaths.
We used the second model (6 months from admission
model) as the number of deaths was higher.
Study endpoints
The main outcome measures were death in-hospital and
6-month mortality (from both hospital admission and
discharge). One-year and five-year mortality after dis-
charge was also measured.
Statistical analysis
Descriptive analyses were used to characterize the study
cohort. Differences between groups defined by age
groups (including by more or less than 55 years to ac-
count for the younger mean age of Aboriginal patients),
sex and Aboriginal and non-Aboriginal status were
tested using the chi-squared test for categorical data and
the t-test for continuous variables.
As the ‘c-statistic’ is most frequently used to report the
discriminatory capacity of prognostic GRACE risk scores,
we plotted the Receiver Operating Characteristic (ROC)
curve of GRACE scores against deaths at 30 days,
6 months and 1 and 5 years for the cohort overall, and for
Aboriginals and non-Aboriginals separately. Calibration
was tested in the ‘admission to 6 months’ model by com-
paring predicted and observed mortality at 6 months. The
Hosmer-Lemeshow ‘p-value’ was obtained from binary lo-
gistic regression models as an indicator of the goodness of
fit of the three models tested.
All analyses were carried out in IBM SPSS Statistics
for Windows, Version 21.0, Armonk, NY: IBM Corp.
Ethics
The study was approved by the Human Research Ethics
Committees at The University of Western Australia, the
Western Australian Department of Health, the Western
Australian Aboriginal Health Ethics Committee, and the
Western Australian Country Health Service.
Results
Of 892 cases who would have met the GRACE study
enrolment criteria, 220 (25 %) were identified as Abori-
ginal Australians. There was considerable disparity in
age, with Aboriginal patients almost 15 years younger
on average than non-Aboriginal patients, 136 (62 %)
being <55 years of age compared with 99 (15 %) non-
Aboriginals (Fig. 2). The demographic and clinical char-
acteristics of the cohort are shown in Table 1.
ACS diagnoses
AMI (STEMI and non-STEMI) was the principal discharge
diagnosis recorded in the HMDC for 277 (41 %) non-
Aboriginal and 128 (58 %) Aboriginal patients (p < 0.001).
Using AHA criteria, a total of 132 cases with STEMI (33 %)
were identified, with a smaller proportion of Aboriginal pa-
tients meeting the criteria for STEMI (Table 1).
Coronary artery reperfusion therapy, either thromboly-
sis or primary percutaneous coronary intervention (PCI)
was undertaken in 89 cases (Table 1), including 55
(61 %) of 90 patients with ST-segment elevation on their
first ECG. The other 34 reperfusions were among 92 pa-
tients with ischaemic changes (subsequently coded as
AHA ‘definite’ or ‘probable’ AMI, with evolving ‘Q-
waves’) and 17 patients with a Minnesota suppression
codes such as bundle-branch blocks (which suppress the
coding of Q waves).
Reperfusion with thrombolysis was more frequent
among those presenting initially to a rural hospital (58 %),
with only one patient from a rural location undergoing
primary PCI. AMI was also more frequently the discharge
diagnosis for patients from rural locations (54 %) than
from the Perth metropolitan area (40 %, p < 0.001).
Mortality
Total deaths in hospital, at 6 months (from admission
and from discharge), and at one and five years were 39
Fig. 2 Distribution by age groups among 892 Aboriginal and non-
Aboriginal patients discharged with a diagnosis of ACS, Western
Australia 2002–2004
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Table 1 Characteristics of the cohort studied, 892 Aboriginal and non-Aboriginal patients discharged from hospital with a diagnosis
of acute coronary syndrome, Western Australia 2002–2004
Non-Aboriginal Aboriginal p
N = 672 N = 220
Males % 472 (70) 132 (60) <0.01
Age - mean (SD) 66.4 (9.7) 52.4 (11.4) <0.001
median (tertile cut points) 68 (63, 73) 52 (47, 57)
Rural or remote dwelling n (%) 154 (23) 114 (52) <0.001
On admission
Systolic Blood Pressure – median (mmHg) 140 135
Heart Rate - median (beats per minute) 75 86
ST-segment deviation on ECG n (%) 199 (30) 77 (35) 0.15
Elevated initial biomarkers n (%) 241 (36) 125 (57) <0.001
AMI 172 (64) 99 (79)
Unstable angina 69 (17) 26 (27)
Killip class n (%)
1 533 (79) 185 (84)
2 92 (14) 22 (10)
3 44 (6) 13 (6)
4 3 (<1) 0
AMI (principal discharge diagnosis) 277 (41) 128 (58) p < 0.001
STEMI AHA criteria* 102 (37) 30 (24)
Reperfusion therapy – (N) 64 20
Reperfusion therapy for STEMI 44 (69) 11 (55)
Thrombolysis (% of reperfusion) 26 (59) 9 (82)
Primary PCI (% of reperfusion) 18 (41) 2 (8)
Reperfusion - ECG with other codes 20 (31) 9 (45)
Thrombolysis 12 (60) 9 (100)
Primary PCI 8 (40) 0
History (within 5 years) n (%)
AMI 210 (31) 65 (30) 0.86
Heart failure 69 (10) 11 (5) <0.01
Coronary artery disease 372 (55) 108 (49) 0.15
Chronic renal failure 14 (9) 34 (16) 0.04
Diabetes 228 (34) 124 (56) <0.001
< 55 years 22 (26) 64 (49) 0.001
≥ 55 years 206 (35) 60 (67) <0.001
In-hospital n (% )
Heart failure 82 (13) 11 (5) <0.01
Arrhythmia 80 (12) 8 (4) <0.001
PCI (excluding primary PCI) 149 (23) 36 (20) 0.22
CABG within 28 days 23 (4) 7 (3) 0.99
*Luepker R, et al. [26]
AMI acute myocardial infarction, STEMI ST-segment elevation myocardial infarction, AHA American Heart Association, PCI percutaneous coronary intervention, CABG
coronary artery bypass graft surgery
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(4 %), 83 (9 %), 46 (6 %), 80 (13 %) and 232 (30 %)
respectively.
Total mortality at each time point favoured Aboriginal
patients (Table 2). After age stratification, mortality was
similar for both groups for those aged 55 years or more,
but was higher among Aboriginal patients <55 years of
age from 6 months after hospital discharge. However,
the numbers of death were too low (except at 5 years) to
show statistical difference.
GRACE scores
The mean and median scores for each of the three GRACE
models (death in-hospital, from admission to 6 months,
and from discharge to 6 months) were lower among Abori-
ginal patients (Table 2). The low scores were related to the
relative youth of the Aboriginal patients, 16 % of whom did
not accrue any points for age (<40 years). Additionally, only
7 %, compared with 42 % of the non-Aboriginal group,
were ≥70 years, an attribute which adds 73 points to the
score (in the discharge to 6 months model).
The age disparity was such that, when stratified into
broad age groups (<55 and 55–79 years), GRACE scores
for Aboriginal patients were equivalent or higher than
those of non-Aboriginals, more noticeably in the youn-
ger group (Table 2).
Distribution of scores
Using the ‘6 months post-discharge’ model to compare
the distribution of scores with those published for the
original GRACE Study cohort [20], the cut points for
tertiles of risk score (0.33, 0.66) were lower for Aborigi-
nal than non-Aboriginal patients, and lower than those
Table 2 GRACE scores from three models, and all-cause mortality, among patients discharged with a diagnosis of acute coronary
syndrome for Aboriginal (n = 220) and non-Aboriginal (n = 672) patients overall and for age groups, Western Australia 2002–2004
Non-Aboriginal Aboriginal Non-Aboriginal Aboriginal ‘p’ (mean)
Median (min, max) Mean (SD)
GRACE Score at admission for death in-hospital
All 115 (34, 264) 100 (33, 227) 181.0 (25.8) 105.2 (38.9) <0.001
< 55 years 75 (34, 163) 88 (33, 73) 117.3 (34.7) 90.2 (32.1) 0.03
≥ 55 years 118 (54, 212) 119 (59, 227) 122.5 (22.6) 126.8 (37.7) 0.26
Death in-hospital n (%) 35 (5) 4 (2)*
< 55 years 2 (2)* 1 (<1)*
≥ 55 years 33 (6) 3 (3)*
GRACE Score at admission for 6-month mortality
All 104 (26, 219) 83 (24, 184) 103.4 (29.5) 86.6 (33.9) <0.001
< 55 years 63 (26, 125) 67 (24, 141) 64.9 (20.4) 70.4 (26.3) 0.11
≥ 55 years 106 (50, 176) 105 (54, 184 108.9 (26.3) 110.1 (29.6) 0.68
6-month mortality n (%) 70 (10) 13 (6) 0.03
< 55 years 2 (2)* 3 (2)* -
≥ 55 years 68 (12) 10 (11) 0.53
GRACE Score at discharge for 6-month mortality
All 109 (28,194) 89 (20,182) 108.8 (29.5) 93.0 (31.6) <0.001
< 55 years 65 (28,103) 77 (20, 138) 68.1 (17.9) 77.0 (24.1) 0.004
≥ 55 years, 112 (54, 194) 116 (68, 182) 114.6 (26.1) 116.0 (26.5) 0.64
6-month mortality n(%) 36 (6) 10 (5) 0.35
< 55 years 0 (0)* 2 (<2)* -
≥ 55 years 36 (7) 8 (9) 0.32
One-year mortality n(%) 66 (10) 14 (7) 0.06
< 55 years 0 (0)* 2 (2)* -
≥ 55 years 66 (12) 12 (14) 0.60
Five-year mortality n(%) 181 (28) 51 (24) 0.10
< 55 years 4 (5) 21 (16) 0.01
≥ 55 years 177 (32) 30 (34) 0.36
*less than 5 cases
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derived from the GRACE Study population. This was so
for STEMI (0.33 corresponds to scores of 85 (Aboriginal),
95 (non-Aboriginal), 99 (GRACE), respectively, and 0.66
to score of 113, 123 and 127, respectively) and non-
STEMI/UA (0.33 = 77, 96, 88 and 0.66 = 104, 121 and 118
respectively). Applying the GRACE study tertiles, >50 %
of Aboriginal patients would be considered low risk for
death within 6 months of discharge for both STEMI and
non-STEMI/UA (Fig. 3). For non-Aboriginal patients the
variations (more at low risk after STEMI, fewer after non-
STEMI/UA) were less marked. The numbers of deaths in
each subgroup (tertiles x Aboriginal or non-Aboriginal x
AMI or non-STEMI/UA) were too few to make any com-
parisons of associated mortality.
Association between GRACE score and outcomes
The ‘admission to 6 month’ model (the highest number
of end-points) was well calibrated overall, with good cor-
relation between the predicted probability of 6-month
all-cause mortality and observed deaths (Fig. 4). The fit
was best for non-Aboriginals, and this resulted in good
overall fit, as non-Aboriginals were 75 % of the cohort. For
Aboriginal people, however, the association was less con-
vincing, with few deaths among the 70 % in the lowest risk
category (<5 % risk), and very few patients in the higher risk
groups (>20 % risk). Observed deaths for the 5 Aboriginal
patients estimated to be at 6-10 % risk of death to
6 months was 15 %, suggesting under-estimation of risk.
There was little difference in the discriminatory cap-
acity of the GRACE models in both Aboriginal and non-
Aboriginal groups, with the c-statistics ranging from
0.75 to 0.79. However, there were low numbers of deaths
and broader confidence intervals throughout for the
Aboriginal cohort (Table 3). Each of the three risk score
models was found to demonstrate ‘goodness of fit’ for
both groups, with Hosmer-Lemeshow ‘p’-values exceed-
ing 0.05 (Table 3).
Discussion
The GRACE risk scores for death in-hospital and to
6 months (from both admission and discharge) have
proven reliable in identifying high-risk cases among
patients presenting with symptoms of an ACS [18]. Test-
ing three of the models in this population demonstrated
that the models retain their prognostic capacity to dis-
criminate between patients at different levels of risk for
all-cause mortality after an admission for ACS, con-
firmed by c-statistics of 0.75 or more for both Aboriginal
and non-Aboriginal patients at time points to five years.
However, in this cohort, selected ‘post-hoc’ to conform
to the GRACE study criteria, crude mortality at each
time point was lower among the Aboriginal patients, a
finding at odds with the reported excess CVD mortality
[1]. Such findings have been reported from studies of out-
comes of AMI, where crude case-fatality after AMI for
Aboriginal and non-Aboriginal patients was similar, but
age-specific rate ratios for Aboriginal patients considerably
Fig. 3 Percentage of patients in tertiles of GRACE risk score for ‘mortality to 6-month post-discharge’ in the GRACE Study cohort*, and for Aboriginal
and non-Aboriginal people in our study
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higher, especially in younger age-groups [11, 12]. The
Aboriginal patients in our study may have been relatively
low-risk, with a smaller proportion having a diagnosis of
STEMI (although more had an AMI diagnosis overall) or
suffering in-hospital complications of heart failure or
arrhythmia. We had too few deaths to reliably estimate any
age-specific outcomes, but stratifying by age <55 years or
55 years or more, there was a trend to more deaths among
young Aboriginal people after hospital discharge.
On the small numbers of deaths from admission to
6 months there was an indication of greater than pre-
dicted mortality among the ‘low-risk’Aboriginal patients,
and the possibility of underestimation of risk is sup-
ported by the equal or higher mean GRACE scores for
both younger and older Aboriginal people after age
stratification. Other than less likelihood of a history of
heart failure, which contributed to lower scores for Abo-
riginal patients, the other elements of the GRACE scores
were equivalent or attracted a higher score for Aborigi-
nal patients. As these factors do not make as significant
a contribution to the score as age, the possibility is that
the dominance of age in the models contributes to an
underestimation of risk, with weightings being less ap-
plicable to Aboriginal Australians.
While lacking the power to demonstrate any system-
atic under-estimation of risk for the GRACE models,
there is some support for the caution from the GRACE
investigators that the risk models may not perform as
well in populations that differ substantially from the
population in which the models were developed [17]. Al-
though the GRACE risk models were developed using
data from patients from over a dozen countries, minority
groups may differ considerably from the study cohort.
This is evident for the distribution of age in the Austra-
lian Aboriginals admitted for ACS; the mean and median
ages in both the GRACE development and validation
cohorts were 65 and 66 years respectively [17] ,a year or
two younger than the non-Aboriginals in this study
(66.4 and 68 years), but more than a decade older than
Aboriginal patients at 52.4 and 52 years.
The GRACE Investigators also cautioned that socio-
economic status had not been included in the construc-
tion of the models, and may well contribute to variability
in risk [17]. As Aboriginal Australians and other indi-
genous minorities within advanced economies are
among the most socially disadvantaged [27], the poten-
tial for confounding is obvious. However, when tested
among patients with AMI in a Canadian study, the
GRACE score was found to be a ‘robust, well-calibrated,
and accurate risk-stratification tool’ both within and
across socioeconomic strata [28]. If the GRACE score
performed well in predicting 6-month all-cause mortality
among patients hospitalized with AMI, regardless of
Table 3 C-statistics* and 95 % CI for three GRACE models for
prediction of death at different time points for Aboriginal and
non-Aboriginal ACS patients
c-statistic (95 % CI)
Group(H-L p-value)* In-hospital 6 months One year Five years





GRACE score on admission : death within 6 months of admission
Aboriginal 0.76 0.78 0.77
(0.10) (0.62–0.89) (0.65–0.91) (0.70–0.85)
Non-Aboriginal 0.79 0.76 0.75
(0.75) (0.74–0.84) (0.71–0.82) (0.71–0.80)
GRACE score at discharge : death within 6 months of discharge
Aboriginal - 0.75 0.77 0.76
(0.30) (0.56–0.94) (0.63–0.92) (0.68–0.84)
Non-Aboriginal - 0.77 0.78 0.76
(0.87) (0.71–0.84) (0.72–0.83) (0.72–0.80)
* H-L = Hosmer-Lemeshow χ2 p-value
Fig. 4 Observed mortality at 6 months from admission among a cohort
of patients admitted with ACS including Aboriginal (n = 13 deaths) and
non-Aboriginal patients (n = 70 deaths) by the probability of death
indicated by the GRACE score*
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socio-economic status, the likelihood of confounding by
socio-economic status is reduced. Other factors (includ-
ing age) are likely to influence the capacity of the score
to accurately predict the risk for death in Aboriginal
patients.
The excessive reduction in Australian Aboriginal life
expectancy (the mortality gap), with early CVD being
the largest contributor, is a reflection of accrual of life-
time cardiovascular risk. ‘Accrued risk’ among Aboriginal
people aged to 50 years was reported to be equivalent to
that of Framingham Study participants aged to 70 years
for men, and to 80 years for women [29]. Other indigen-
ous populations in which high prevalence of CVD risk
factors are reported [2, 4, 5, 7, 30, 31], and in which
CVD is manifest at a younger age, include American In-
dians and Alaskan Natives, Canadian First Nations and
Inuit peoples, and the Māori of New Zealand [2–7]. The
increased rates of CVD reported for some ethnic groups,
associated with changes in lifestyle with immigration,
[31–34] are also likely to have distributions of risk that
differ significantly from the general population. Oppor-
tunities to test the GRACE models in such populations
would lead to a better understanding of risk stratifica-
tion for management of ACS and, plausibly, better out-
comes for minority groups.
Study limitations
Missing data for calculating the GRACE scores (e.g. ini-
tial enzyme levels and serum creatinine, ECG, medical
history not recorded on data collection form) reduced
the ACS cases available for both groups. Despite sam-
pling to capture all ACS admissions among Aboriginal
people in the state population across three years only
220 cases had complete data and met the criteria for this
study. In addition case-fatality was low for Aboriginal
patients, with only four in-hospital deaths and 10 further
deaths within six months of discharge, while the rate
was as predicted for the non-Aboriginal population. The
resulting lack of power left us unable to undertake any
analyses that might improve risk stratification among
Aboriginal patients, and provide more useful estimates
of low, medium and high risk in this population.
The diagnosis of AMI, ACS or unstable angina was
that recorded at discharge, rather than on admission as
for patients in the GRACE studies. The discharge diag-
nosis reflects medical decision-making using all the clin-
ical data collected during the admission. For instance,
positive biomarkers were not always associated with a
discharge diagnosis of AMI, suggesting other clinical
data had been taken into consideration.
Significance
This is the first study to undertake a validation of a
widely-used ACS risk stratification model in an Indigenous
Minority population. Australian Aboriginals are around 3 %
of Australia’s population while 1.7 % of the population of
the United States identified as American Indian and Alaska
Native, either alone or in combination with one or more
other races in 2010 [35], and 4.3 % of Canadians reported
an Aboriginal identity in 2011 [36]. Māori are a larger Indi-
genous Minority, being 15.4 % of the New Zealand popula-
tion in 2012 [37]. The small size of these populations
means that studies are burdened with comparatively low
numbers, but the importance of the disparity in morbidity
and mortality requires that attention is paid to informa-
tion that may lead to improvements in disease prevention,
detection, and management.
Clinical registries provide the opportunity to under-
stand the risks for and the presentation, management
and outcomes of admission of cardiovascular disease.
Every effort should be made to ensure Indigenous
Minorities are fully represented in such projects.
Conclusions
The GRACE risk models are useful tools for predicting
the risk for in-hospital deaths and all-cause mortality at
six months among patients with ACS, but may under-
estimate risk among Australian Aboriginals who differ
significantly from the general population in the age
distribution of ACS. If this is the case in other Indigen-
ous or minority populations then re-calibration of the
models is necessary to provide more accurate prognostic
tools to guide intervention and ongoing management.
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